Provided by Tiger Trade Technology Pte. Ltd.

PMV Pharmaceuticals

1.10
+0.06005.77%
Post-market: 1.130.0300+2.73%19:47 EST
Volume:390.19K
Turnover:418.15K
Market Cap:58.53M
PE:-0.69
High:1.12
Open:1.05
Low:1.03
Close:1.04
52wk High:1.84
52wk Low:0.8100
Shares:53.21M
Float Shares:36.20M
Volume Ratio:1.29
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5845
EPS(LYR):-1.1382
ROE:-51.87%
ROA:-32.02%
PB:0.48
PE(LYR):-0.97

Loading ...

Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025

Major Issues Report

Form 8-K - Current report
Oct 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 09, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 25, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]